BayWa's Legal and Financial Quagmire Leaves Investors in Limbo

BayWa faces shareholder lawsuits, a PwC probe, and a stalled €4B asset sale. Key financial clarity is delayed until late 2026, eroding investor confidence.

Investors in German agricultural trader BayWa face a prolonged period of uncertainty, with a perfect storm of legal challenges and a stalled financial restructuring likely to obscure the company's true valuation until late 2026. The convergence of these crises has left the stock trading roughly 20% below its 200-day moving average, reflecting a deep erosion of market confidence.

The legal onslaught stems from a formal reprimand by German financial watchdog BaFin. The company's 2023 management report omitted crucial details regarding a billion-euro loan and specific refinancing risks tied to a €500 million bond. Law firm TILP is preparing legal action on behalf of shareholders who invested between January 2022 and January 2026, targeting both the company and former board members. Former CEO Marcus Pöllinger is among the ex-executives under investigation by the Munich I public prosecutor's office on suspicion of breach of trust.

Auditor PricewaterhouseCoopers is also in the crosshairs. PwC issued an unqualified audit opinion for 2023 without highlighting these existential risks, prompting the audit oversight body Apas to initiate a professional conduct investigation. BayWa is now severing ties with PwC and putting its audit mandate out to tender. While PwC will audit the 2025 accounts for the last time, the certified group financial statements for that year are not expected until the fourth quarter of 2026, delayed by a pending revaluation of the energy subsidiary BayWa r.e. The current management is also examining concrete claims for damages against the auditors.

Financially, the company's four-billion-euro divestment target appears increasingly distant, with only €1.3 billion secured so far. A central pillar of the plan—the sale of a 51% stake in BayWa r.e. for up to €1.7 billion—collapsed after U.S. renewable energy subsidies were cut in early 2025, causing the achievable sale price to vanish. The focus has now shifted to the planned sale of New Zealand fruit trader T&G Global, with Goldman Sachs mandated in March 2026. Analysts estimate proceeds of around €300 million, though the process is complicated by minority shareholder Joy Wing Mau, which holds nearly 20% of T&G Global. The subsidiary itself has stated no final decision has been made.

A modest liquidity injection is expected by April 30, with a final €45 million payment from the sale of grain trading unit Cefetra, plus approximately €62 million from repaid shareholder loans. The deconsolidation of Cefetra is projected to reduce group bank loans by over €600 million. In the current climate, these incoming funds serve primarily as bargaining chips with creditors. The core banking syndicate, led by DZ Bank and HVB, has yet to agree to extend the standstill agreement until autumn 2026. The severity of the situation is underscored by actions of the Bavarian cooperative banks, which have already written down €132 million from a €220 million promissory note in their 2024 accounts.

Internally, governance is being tightened. The supervisory board has lowered the approval threshold for transactions from €200 million to €50 million. Three board members have recently departed, with successors awaiting confirmation at the next annual general meeting, for which no firm date is set.

With the 2026 annual forecast withdrawn and the adjusted EBITDA target for 2027 lowered to around €140 million, the path forward hinges on two late-2026 events: a bank agreement and the delivery of audited financial statements. Until then, shareholders are navigating in the dark. The stock, having lost over a third of its value from its 52-week high of €21.50, continues to exhibit high volatility, trading with a Relative Strength Index (RSI) of 80 despite the persistent downtrend—a signal of sharp swings rather than stability.